Amneal Pharmaceuticals, Inc. (AMRX)

19.84 +0.48 (+2.48%) USD  |  NASDAQ  |  Oct 20, 16:00
19.80 -0.04 (-0.20%) After-Hours: 07:09
More

Amneal Pharmaceuticals Gross Profit (TTM) : 1.226B for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.226B
March 31, 2026 1.178B
December 31, 2025 1.113B
September 30, 2025 1.079B
June 30, 2025 1.075B
March 31, 2025 1.038B
December 31, 2024 1.020B
September 30, 2024 983.49M
June 30, 2024 946.46M
March 31, 2024 916.54M
December 31, 2023 856.66M
September 30, 2023 851.45M
June 30, 2023 813.82M
March 31, 2023 799.43M
December 31, 2022 795.82M
September 30, 2022 763.51M
June 30, 2022 767.81M
March 31, 2022 774.67M
December 31, 2021 791.66M
September 30, 2021 770.33M
June 30, 2021 737.08M
March 31, 2021 669.58M
December 31, 2020 662.97M
September 30, 2020 619.86M
June 30, 2020 564.47M
Date Value
March 31, 2020 527.74M
December 31, 2019 479.16M
September 30, 2019 549.81M
June 30, 2019 647.15M
March 31, 2019 717.18M
December 31, 2018 725.40M
September 30, 2018 682.21M
June 30, 2018 609.32M
March 31, 2018 554.76M
December 31, 2017 410.16M
September 30, 2017 328.12M
June 30, 2017 298.04M
March 31, 2017 248.80M
December 31, 2016 352.78M
September 30, 2016 398.18M
June 30, 2016 389.19M
March 31, 2016 399.56M
December 31, 2015 354.80M
September 30, 2015 300.86M
June 30, 2015 289.34M
March 31, 2015 314.26M
December 31, 2014 315.55M
September 30, 2014 287.65M
June 30, 2014 264.76M
March 31, 2014 213.87M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Liquidia Corp. 416.18M
Eli Lilly & Co. 66.44B
Johnson & Johnson 68.45B
Merck & Co., Inc. 48.01B
Viatris, Inc. 5.838B